(AKTX) Akari Therapeutics - Performance -59.2% in 12m
AKTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-88.28%
#179 in Peer-Group
Rel. Strength
6.96%
#7141 in Stock-Universe
Total Return 12m
-59.23%
#171 in Peer-Group
Total Return 5y
-97.34%
#180 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.30 USD |
| 52 Week Low | 0.87 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 53.03 |
| Buy/Sell Signal +-5 | 1.43 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AKTX (-59.2%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: AKTX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AKTX
| Total Return (including Dividends) | AKTX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -13.33% | 2.14% | 5.25% |
| 3 Months | 4.91% | 0.64% | 24.13% |
| 12 Months | -59.23% | -4.57% | 14.15% |
| 5 Years | -97.34% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | AKTX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -66.3% | 35.8% | 81% |
| 3 Months | -21.2% | -28.5% | 96.9% |
| 12 Months | -70.5% | -74.5% | 44.9% |
| 5 Years | -95.8% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th12.00 | -15.15% | -17.65% |
| 3 Month | %th38.50 | 4.25% | -15.48% |
| 12 Month | %th15.50 | -57.28% | -64.29% |
| 5 Years | %th10.50 | -98.14% | -98.74% |
FAQs
Does Akari Therapeutics (AKTX) outperform the market?
No,
over the last 12 months AKTX made -59.23%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months AKTX made 4.91%, while XLV made 0.64%.
Performance Comparison AKTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AKTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.8% | -18.6% | -20.9% | -73% |
| US NASDAQ 100 | QQQ | -0.5% | -18.6% | -21.5% | -72% |
| German DAX 40 | DAX | 1.4% | -11.9% | -33% | -88% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.6% | -16.6% | -24.3% | -79% |
| Hongkong Hang Seng | HSI | -0.4% | -19.4% | -40.3% | -98% |
| India NIFTY 50 | INDA | 1.1% | -16.8% | -21.2% | -58% |
| Brasil Bovespa | EWZ | -3.2% | -22.1% | -45.9% | -69% |
AKTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.6% | -19.2% | -25% | -84% |
| Consumer Discretionary | XLY | -0.3% | -16.5% | -13.2% | -77% |
| Consumer Staples | XLP | -1.1% | -14% | -22.5% | -68% |
| Energy | XLE | -1.1% | -20.4% | -16.8% | -59% |
| Financial | XLF | -1.5% | -18.4% | -25.8% | -89% |
| Health Care | XLV | -0.2% | -15.5% | -13.5% | -55% |
| Industrial | XLI | -0.9% | -17.5% | -28.7% | -84% |
| Materials | XLB | -3% | -17.6% | -25.4% | -65% |
| Real Estate | XLRE | -0.7% | -14.3% | -20.6% | -72% |
| Technology | XLK | -1.5% | -22% | -23.2% | -70% |
| Utilities | XLU | 0.3% | -15.1% | -24.1% | -82% |
| Aerospace & Defense | XAR | 1.4% | -20.4% | -39.5% | -109% |
| Biotech | XBI | -1.8% | -16.7% | -7.7% | -52% |
| Homebuilder | XHB | -3.3% | -20.4% | -13.7% | -65% |
| Retail | XRT | -3.3% | -18.3% | -16.6% | -71% |
AKTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.7% | -21.8% | -12.5% | -52% |
| Natural Gas | UNG | 8.7% | -3.5% | -4.1% | -57% |
| Gold | GLD | -1% | -12.1% | -41.5% | -98% |
| Silver | SLV | -1.8% | -20.3% | -38.2% | -77% |
| Copper | CPER | 0.2% | -17.9% | -38% | -70% |
AKTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.1% | -14.4% | -17.5% | -57% |
| iShares High Yield Corp. Bond | HYG | 0.4% | -14.9% | -19.8% | -69% |